These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23871804)

  • 1. Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma.
    Lin ZY; Wu CC; Chuang YH; Chuang WL
    Life Sci; 2013 Sep; 93(8):323-8. PubMed ID: 23871804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts.
    Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2013 Jun; 29(6):312-8. PubMed ID: 23684136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells.
    Lin ZY; Chuang YH; Chuang WL
    Biomed Pharmacother; 2012 Oct; 66(7):525-9. PubMed ID: 22739041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic concentrations of ascorbic acid cause diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines.
    Lin ZY; Chuang WL
    Biomed Pharmacother; 2010 May; 64(5):348-51. PubMed ID: 19932582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically acceptable colchicine concentrations have potential for the palliative treatment of human cholangiocarcinoma.
    Wu CC; Lin ZY; Kuoc CH; Chuang WL
    Kaohsiung J Med Sci; 2015 May; 31(5):229-34. PubMed ID: 25910557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines.
    Lin ZY; Kuo CH; Wu DC; Chuang WL
    Kaohsiung J Med Sci; 2016 Feb; 32(2):68-73. PubMed ID: 26944324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High therapeutic concentration of prazosin up-regulates angiogenic IL6 and CCL2 genes in hepatocellular carcinoma cells.
    Lin ZY; Chuang WL
    Biomed Pharmacother; 2012 Dec; 66(8):583-6. PubMed ID: 23089469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphotericin B up-regulates angiogenic genes in hepatocellular carcinoma cell lines.
    Lin ZY; Chuang WL; Chuang YH
    Eur J Clin Invest; 2009 Mar; 39(3):239-45. PubMed ID: 19260954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrary influence of clinically applied sorafenib concentrations among hepatocellular carcinoma patients.
    Lin ZY; Chuang WL
    Biomed Pharmacother; 2017 Feb; 86():27-31. PubMed ID: 27936391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
    Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
    J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
    Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
    Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.
    Li X; Zhu Y; He H; Lou L; Ye W; Chen Y; Wang J
    Biochem Biophys Res Commun; 2013 Jun; 436(2):259-64. PubMed ID: 23726914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice].
    Song CC; Lu X; Cheng BB; DU J; Li B; Ling CQ
    Ai Zheng; 2007 Dec; 26(12):1315-22. PubMed ID: 18076793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
    Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
    Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma.
    Wada A; Fukui K; Sawai Y; Imanaka K; Kiso S; Tamura S; Shimomura I; Hayashi N
    J Hepatol; 2006 Jan; 44(1):142-50. PubMed ID: 16298452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the Chinese traditional medicinal herb Celastrus orbiculatus Thunb on human hepatocellular carcinoma in an orthothopic fluorescent nude mouse model.
    Wang M; Zhang X; Xiong X; Yang Z; Sun Y; Yang Z; Hoffman RM; Liu Y
    Anticancer Res; 2012 Apr; 32(4):1213-20. PubMed ID: 22493351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.